Title:
抗原特異的製剤の投与による免疫疾患の治療
Document Type and Number:
Japanese Patent JP7376208
Kind Code:
B2
Abstract:
The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
Inventors:
Potts, Emil Richard George
Leenhouts, Cornelis Johannes
Sorensen, Paul
Leenhouts, Cornelis Johannes
Sorensen, Paul
Application Number:
JP2020543712A
Publication Date:
November 08, 2023
Filing Date:
October 25, 2018
Export Citation:
Assignee:
ALLERO THERAPEUTICS BV
International Classes:
A61K39/39; A61K9/06; A61K9/70; A61K39/00; A61K47/34; A61K47/42; A61P3/10; A61P11/02; A61P11/06; A61P17/00; A61P19/02; A61P21/04; A61P25/00; A61P27/14; A61P29/00; A61P37/02; A61P37/08; A61P43/00
Domestic Patent References:
| JP2004527450A | ||||
| JP2017510268A | ||||
| JP2017040544A |
Foreign References:
| WO2010098429A1 |
Other References:
MASEK, J. et al,Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines,Journal of Controlled Release,2017年08月18日,Vol.249,pp.183-195
Attorney, Agent or Firm:
Ikeda Adult
Junichiro Sakamaki
Masakazu Noda
Nomura Risa
Yuji Wada
Junichiro Sakamaki
Masakazu Noda
Nomura Risa
Yuji Wada